FI951760L - Gestageenisesti vaikuttavat 19,11-silloitetut 4-estreenit - Google Patents

Gestageenisesti vaikuttavat 19,11-silloitetut 4-estreenit Download PDF

Info

Publication number
FI951760L
FI951760L FI951760A FI951760A FI951760L FI 951760 L FI951760 L FI 951760L FI 951760 A FI951760 A FI 951760A FI 951760 A FI951760 A FI 951760A FI 951760 L FI951760 L FI 951760L
Authority
FI
Finland
Prior art keywords
estrenes
progestogenic
linked
Prior art date
Application number
FI951760A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI951760A0 (fi
FI951760A7 (fi
Inventor
Eckhard Ottow
Wolfgang Schwede
Wolfgang Halfbrodt
Karl-Heinrich Fritzemeier
Rolf Krattenmacher
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI951760A0 publication Critical patent/FI951760A0/fi
Publication of FI951760A7 publication Critical patent/FI951760A7/fi
Publication of FI951760L publication Critical patent/FI951760L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Investigation Of Foundation Soil And Reinforcement Of Foundation Soil By Compacting Or Drainage (AREA)
  • Glass Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Eye Examination Apparatus (AREA)
  • Toys (AREA)
FI951760A 1992-10-13 1993-10-13 Gestageenisesti vaikuttavat 19,11-silloitetut 4-estreenit FI951760L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4235220A DE4235220A1 (de) 1992-10-13 1992-10-13 Gestagen wirksame 19,11ß-überbrückte 4-Estrene
PCT/EP1993/002823 WO1994009025A1 (de) 1992-10-13 1993-10-13 Gestagen wirksame 19,11-überbrückte 4-estrene

Publications (3)

Publication Number Publication Date
FI951760A0 FI951760A0 (fi) 1995-04-12
FI951760A7 FI951760A7 (fi) 1995-04-12
FI951760L true FI951760L (fi) 1995-04-12

Family

ID=6470806

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951760A FI951760L (fi) 1992-10-13 1993-10-13 Gestageenisesti vaikuttavat 19,11-silloitetut 4-estreenit

Country Status (25)

Country Link
US (2) US5523298A (da)
EP (1) EP0664811B1 (da)
JP (1) JP3302366B2 (da)
KR (1) KR100341066B1 (da)
CN (1) CN1052238C (da)
AT (1) ATE156837T1 (da)
AU (1) AU677019B2 (da)
BR (1) BR9307232A (da)
CA (1) CA2146962A1 (da)
CZ (1) CZ284187B6 (da)
DE (2) DE4235220A1 (da)
DK (1) DK0664811T3 (da)
ES (1) ES2108298T3 (da)
FI (1) FI951760L (da)
GR (1) GR3024940T3 (da)
HU (1) HU223315B1 (da)
IL (1) IL107232A (da)
NO (1) NO305440B1 (da)
NZ (1) NZ256865A (da)
PL (1) PL179764B1 (da)
RU (1) RU2157814C2 (da)
SK (1) SK280991B6 (da)
TW (1) TW341575B (da)
WO (1) WO1994009025A1 (da)
ZA (1) ZA937614B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4235220A1 (de) * 1992-10-13 1994-06-16 Schering Ag Gestagen wirksame 19,11ß-überbrückte 4-Estrene
DE4413185A1 (de) * 1994-04-12 1995-10-19 Schering Ag 11beta,19-überbrückte 13alpha-Alkylsteroide
DE4413184A1 (de) * 1994-04-12 1995-10-19 Schering Ag 10,11-C¶3¶-überbrückte Steroide
US5912006A (en) * 1996-08-28 1999-06-15 Eboc, Inc. Compositions and methods for alleviating discomforting menstrual pain
AU2002219218A1 (en) * 2000-12-28 2002-07-16 Schering Ag Method for screening for progesterone receptor isoform-specific ligands
US20040121304A1 (en) * 2001-12-21 2004-06-24 Ulrike Fuhrmann Method for screening for progesterone receptor isoform-specific ligands and for tissue-selective progesterone receptor ligands
GB0219345D0 (en) * 2002-08-20 2002-09-25 Givaudan Sa Improvements in or relating to organic compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU139639A1 (ru) * 1960-03-28 1960-11-30 Н.В. Маревич Крепь дл поддержани междуэтажных целиков при щитовой системе разработки
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
US4361559A (en) * 1981-08-20 1982-11-30 E. R. Squibb & Sons, Inc. Antiinflammatory 17,17-bis (substituted thio) androstenes
DE3708942A1 (de) * 1987-03-18 1988-09-29 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
US5446178A (en) * 1987-03-18 1995-08-29 Schering Aktiengesellschaft Process for preparing 19,11β-bridged steroids
DE3717169A1 (de) * 1987-05-19 1988-12-01 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3832303A1 (de) * 1988-09-20 1990-04-12 Schering Ag 11ss-phenyl-14ssh-steroide
DE3917274A1 (de) * 1989-05-24 1990-11-29 Schering Ag 9(alpha)-hydroxy-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4038128A1 (de) * 1990-11-27 1992-06-04 Schering Ag 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4235220A1 (de) * 1992-10-13 1994-06-16 Schering Ag Gestagen wirksame 19,11ß-überbrückte 4-Estrene

Also Published As

Publication number Publication date
IL107232A0 (en) 1994-01-25
HU9501057D0 (en) 1995-06-28
BR9307232A (pt) 1999-08-24
FI951760A0 (fi) 1995-04-12
SK49495A3 (en) 1995-08-09
SK280991B6 (sk) 2000-10-09
RU95109891A (ru) 1997-02-10
US5523298A (en) 1996-06-04
CN1092428A (zh) 1994-09-21
EP0664811A1 (de) 1995-08-02
HUT71523A (en) 1995-12-28
KR100341066B1 (ko) 2002-12-06
CZ284187B6 (cs) 1998-09-16
AU677019B2 (en) 1997-04-10
PL308349A1 (en) 1995-07-24
DK0664811T3 (da) 1998-03-30
HU223315B1 (hu) 2004-05-28
FI951760A7 (fi) 1995-04-12
US5703066A (en) 1997-12-30
JP3302366B2 (ja) 2002-07-15
EP0664811B1 (de) 1997-08-13
CN1052238C (zh) 2000-05-10
KR950703576A (ko) 1995-09-20
JPH08502276A (ja) 1996-03-12
NO951444L (no) 1995-06-13
CA2146962A1 (en) 1994-04-28
NO951444D0 (no) 1995-04-12
RU2157814C2 (ru) 2000-10-20
NZ256865A (en) 1996-04-26
DE4235220A1 (de) 1994-06-16
IL107232A (en) 1998-06-15
WO1994009025A1 (de) 1994-04-28
NO305440B1 (no) 1999-05-31
TW341575B (en) 1998-10-01
GR3024940T3 (en) 1998-01-30
CZ91995A3 (en) 1995-09-13
PL179764B1 (pl) 2000-10-31
ZA937614B (en) 1994-05-23
AU5177493A (en) 1994-05-09
ES2108298T3 (es) 1997-12-16
DE59307133D1 (de) 1997-09-18
ATE156837T1 (de) 1997-08-15

Similar Documents

Publication Publication Date Title
FI953489A0 (fi) 2,6-diaminopuriinijohdannaisia
FI954651A7 (fi) Mahdollisesti substituoidut 6,8-kinoliinit
NO920018D0 (no) 1,3-oksatiolannukleosidanaloger
DE69334073D1 (de) Alkalimetall-8,9-Dehydroestronsulfatester
FI961809L (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
FI923314L (fi) Substituerade cyklopropylamino-1,3,5-triaziner
FI935260A7 (fi) Telekommunikationssystem, i vilket debiteringsdatan registreras i handtelefonen
AT397656B (de) (6,7-substituierte-8-alkoxy-1-cyclopropyl-1,4-
BR9506532A (pt) 1,2,3,4,-Tetraidro-5-Nitro-Pirimidinas substituidas
FI933151L (fi) 5,10 metylentetrahydrofolsyre-cyklodextrin-inneslutningsfoereningar
FI930296L (fi) 1,4-disubstituerade piperaziner
NO930926D0 (no) 2-oksokinolinderivater
NO932842D0 (no) 1,4-benzodioksanderivater
FI932516A7 (fi) Styrkonsol, i synnerhet foer motorfordon
FI931747A0 (fi) Reflexkropp, isynnerhet foer vaegmarkeringar
FI931459L (fi) Sammansaettningar med 1-klor-2,2,2-trifluoretyldifluor-metyleter
DE59308564D1 (de) 2,4-Dialkyl-6-sec-alkylphenole
FI932874L (fi) 6,7-modifierade 11b-aryl-4-estrener
FI951760L (fi) Gestageenisesti vaikuttavat 19,11-silloitetut 4-estreenit
FI934928A7 (fi) Foerfarande foer framstaellning av 3,7-dialkylxantiner fraon 3-alkylxantiner
FI932396A7 (fi) Foerfarande foer framstaellning av en dubbelskyddad 2,3-hydroximetylcyklobutanol
FI931794L (fi) Monokvaternaera 2,16-bispiperidinylandrostanderivat
FI930237L (fi) Foerfarande foer framstaellning av 4,6-dialkoxipyrimidiner
FI933872A7 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4H)-on-derivat
BR9508248A (pt) 1,2,4,6-Tiatriazinas herbicidas